EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Christina Lake Cannabis Corp (CLCFF) fair value: what the stock is really worth

As of Sep 28, 2026: fair value of Christina Lake Cannabis Corp $0.02, price $0.02, upside +31.1%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US

CL Christina Lake Cannabis Corp logo Thin data Sep 24, 2026

Christina Lake Cannabis Corp

CLCFF · US

SpeculativeUpside exists, but weak quality makes the signal speculative.

✓Fair value $0.0236 · Undervalued (+31.1%)
!Quality 35/100
!Mixed Growth (revenue 3y +55.3 %/yr)
!Thin margins · 9.4% net margin (TTM)
!Moderate debt · negative free cash flow
✓Ranks above peers (9/12)
!Moderate moat 60/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.4160 $0.0150 Fair Value $0.0236 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $0.0150 – $0.4160 · fair‑value band $0.0198 – $0.0274 · the $0.0180 price screens below the $0.0236 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Christina Lake Cannabis in your weekly email

Every Wednesday you see whether Christina Lake Cannabis is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp.

Show more

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.

Stock analysis

Christina Lake Cannabis Corp (CLCFF) currently trades at $0.0180, while our model-based Fair Value estimate is $0.0236, implying the stock looks roughly 23.7% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $0.1000 per share, and 14 of the 14 models we run sit above the $0.0180 price.

Bear case: the Asset-Based group reads lowest at $0.0200, and 0 of the 14 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.0198 (bear) to $0.0274 (bull), the price of $0.0180 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Christina Lake Cannabis Corp reported revenue of C$13.6M in FY2024 versus C$0 in FY2020. Reported net income was C$865K in FY2024.

Key figures

Market cap $5.0M · P/E ratio 1.8 · P/S ratio 0.11 · EPS (TTM) $0.0100 · Net margin 6.4% · Return on equity 9.5% · Return on assets (EBIT) −11.4% · Operating margin 43.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 55% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 31%, CLCFF screens cheaper than that median.

Fair Value models

Bear $0.0198 Fair Value $0.0236 Bull $0.0274
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then ($0.0100 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV $0.0500 $0.0600 $0.0700 71
Residual Income $0.0300 $0.0300 $0.0300 68
ROIC Compounder $0.0700 $0.1100 $0.1400 68
All 14 models by family
Earnings-Based
Graham-Dodd $0.0200 $0.1200 $0.1600 61
Lynch FV $0.0500 $0.0800 $0.1000 58
PEG = 1.0 $0.0500 $0.0800 $0.1000 55
EPV $0.0500 $0.0600 $0.0700 71
Multiples
P/E Multiple $0.0400 $0.0500 $0.0700 62
P/S Multiple $0.0300 $0.0400 $0.0500 58
P/B Multiple $0.0300 $0.0400 $0.0500 55
EV/EBIT $0.1000 $0.1400 $0.1800 66
EV/EBITDA $0.0900 $0.1300 $0.1600 67
EV/Revenue $0.0700 $0.1000 $0.1400 53
Asset-Based
NCAV (Graham) $0.0200 $0.0200 $0.0300 55
Economic Profit
Residual Income $0.0300 $0.0300 $0.0300 68
ROIC Compounder $0.0700 $0.1100 $0.1400 68
Growth Earnings
Growth-Adj P/E $0.0700 $0.1000 $0.1300 65

Open the full fair value analysis →

Notify me when CLCFF reaches fair value

Put CLCFF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 35/100

Of which business quality 32 · Market factors (momentum, volatility) 24

Profitability 44
Margins and returns on capital today
Quality Growth 74
Are margins and returns improving?
Cashflow 5
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 18
Price trend over the last 3–12 months (market factor)
52W Momentum 6
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 39/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−140.3% (2021) → 22.8% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Watch CLCFF, get fair value alerts →

Compare Christina Lake Cannabis Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 624 stocks

Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Fair Value upside +31.1% · Top 25%
Profitability
Return on equity (TTM) 9.5% · Above median
Return on assets 10.6% · Top 25%
Net margin (TTM) 9.4% · Above median
Operating margin (TTM) 43.8% · Top 25%
Growth and dividend
Revenue growth −2.2% · Below median
Balance sheet
Debt / equity 0.56× · Highest 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/E (TTM) 1.8× · Cheapest 25%
P/B 0.46× · Cheapest 25%
P/S (TTM) 0.33× · Cheapest 25%
EV/EBITDA 2.5× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)75 · sector 16
FUTURE (revenue growth)0 · sector 18
PAST (return on equity)38 · sector 25
HEALTH (low debt)72 · sector 96
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €135.00 €108.94 −19%
Takeda Pharmaceutical Company TAK $18.90 $11.45 −39%
Teva Pharmaceutical Industries Limited TEVA $39.19 $20.88 −47%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,852 ₹1,979 +7%
Galderma Group GALD CHF 163.00 CHF 110.32 −32%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥44.86 ¥49.35 +10%
Haleon plc HLN $9.26 $8.49 −8%
Sandoz Group SDZ CHF 71.16 CHF 40.32 −43%
Zoetis Inc ZTS $71.05 $110.50 +56%
Divi's Laboratories Limited DIVISLAB ₹9,620 ₹1,871 −81%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Christina Lake Cannabis Corp Fair Value". https://www.fairvalue-calculator.com/stock/CLCFF

Frequently asked questions

Is Christina Lake Cannabis Corp (CLCFF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0236 versus a price of $0.0180, about +31% upside (undervalued).
What is the fair value of CLCFF?
Our model-based fair value for Christina Lake Cannabis Corp is $0.0236 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.0180.
What is the quality score of CLCFF?
Christina Lake Cannabis Corp has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Christina Lake Cannabis Corp (CLCFF)?
Our model-based price target is the fair value of $0.0236 (as of Sep 24, 2026) from 14 valuation models. Cautious scenario $0.0198, optimistic scenario $0.0274. It is a calculation from audited fundamentals, not an analyst target.
What is the Christina Lake Cannabis Corp stock forecast for 2026?
Our models put fair value at $0.0236, about +31% upside versus a price of $0.0180 (undervalued). Cautious scenario $0.0198, optimistic scenario $0.0274. The calculation is refreshed regularly with new filings.
What is the revenue of Christina Lake Cannabis Corp (CLCFF)?
Christina Lake Cannabis Corp reported trailing-twelve-month revenue of about $15.1M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Christina Lake Cannabis Corp (CLCFF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Christina Lake Cannabis Corp it is $0.0236 per share (as of Sep 24, 2026), against a price of $0.0180. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Christina Lake Cannabis Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CLCFF trades below its calculated fair value: price $0.0180, fair value $0.0236, a gap of about +31% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CLCFF?
No. The price is what the market pays today ($0.0180); the fair value is what the company's own numbers justify ($0.0236). For Christina Lake Cannabis Corp the two are $0.0056 per share apart. That gap is exactly why we show both numbers side by side.
How much is Christina Lake Cannabis Corp worth?
The market values Christina Lake Cannabis Corp at about $5.0M (market capitalisation, as of Sep 24, 2026). Per share that is $0.0180; our models calculate a fair value of $0.0236 per share.
What do the bullish and bearish scenarios say about CLCFF?
Our models span a range for Christina Lake Cannabis Corp: cautious scenario $0.0198, base $0.0236, optimistic $0.0274 per share (as of Sep 24, 2026, price $0.0180). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CLCFF?
Christina Lake Cannabis Corp trades at a price-to-earnings ratio of 1.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.0236 is built from several models across several years. Other multiples: P/B 0.5, P/S 0.3, EV/EBITDA 2.5.
How solid is the balance sheet of Christina Lake Cannabis Corp (CLCFF)?
Balance-sheet figures for Christina Lake Cannabis Corp (as of Sep 24, 2026): return on equity 9.5%, debt of 0.56 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is CLCFF from its 52-week high?
Christina Lake Cannabis Corp trades at $0.0180, about 55% below its 52-week high of $0.0400 and 20% above the low of $0.0150 (as of Sep 28, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0236 is for.
Which stocks are comparable to Christina Lake Cannabis Corp?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Christina Lake Cannabis Corp stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0180, calculated fair value $0.0236 (+31%), Quality Score 35/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CLCFF calculated?
We run Christina Lake Cannabis Corp through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0236, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Christina Lake Cannabis Corp currently trades 24 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Christina Lake Cannabis Corp (CLCFF)?
The closing price on Sep 28, 2026 was $0.0180. Our model-based fair value is $0.0236, about +31% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Christina Lake Cannabis Corp right now?
The large discount to fair value meets weak quality (35/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0198). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Christina Lake Cannabis Corp

How large is the market capitalisation of Christina Lake Cannabis Corp (CLCFF)?
The market capitalisation of Christina Lake Cannabis Corp is $5.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Christina Lake Cannabis Corp (CLCFF)?
The price-to-sales ratio of Christina Lake Cannabis Corp is 0.11 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Christina Lake Cannabis Corp (CLCFF)?
Earnings per share at Christina Lake Cannabis Corp are $0.0100 (price ÷ EPS = P/E 1.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Christina Lake Cannabis Corp (CLCFF)?
The net margin of Christina Lake Cannabis Corp is 6.4% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Christina Lake Cannabis Corp (CLCFF)?
The return on equity (ROE) of Christina Lake Cannabis Corp is 9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Christina Lake Cannabis Corp (CLCFF)?
On an EBIT basis the return on assets of Christina Lake Cannabis Corp is −11.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Christina Lake Cannabis Corp (CLCFF)?
The operating margin of Christina Lake Cannabis Corp is 43.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Christina Lake Cannabis Corp (CLCFF)?
Revenue at Christina Lake Cannabis Corp is growing −2.2% versus a year earlier (3y avg +55.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Christina Lake Cannabis Corp (CLCFF)?
Earnings per share at Christina Lake Cannabis Corp are growing −55.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Christina Lake Cannabis Corp (CLCFF) generate?
The free cash flow of Christina Lake Cannabis Corp is −$4.1M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Christina Lake Cannabis Corp (CLCFF) carry?
The net debt of Christina Lake Cannabis Corp is $8.1M (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Christina Lake Cannabis Corp in the live analysis

One click puts Christina Lake Cannabis Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.